logo

For the Inventor, By the Inventor

Cesario V Borlongan

Odessa, FL, United States of America

Cesario V Borlongan

Webpage

This inventor holds 14 USPTO granted patents and 1 published patent application, primarily in Stem Cell Therapy. Top assignees: University of South Florida, The United States Government as Represented by the Department of Veterans Affairs, Cryo-Cell International, Inc.. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cesario V Borlongan. Retrieved from https://idiyas.com/inventor/cesario-v-borlongan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 71.4

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Silver Springs, MD (US) (1999)
  • Lutz, FL (US) (1997 - 2000)
  • Baltimore, MD (US) (2003)
  • Augusta, GA (US) (2010 - 2013)
  • Odessa, FL (US) (2015)
  • Tampa, FL (US) (2017 - 2020)

Company Filing History:

goldMedal13 out of 1,993 
 
University of South Florida
 patents
silverMedal3 out of 961 
 
The United States Government as Represented by the Department of Veterans Affairs
 patents
bronzeMedal1 out of 16 
 
Cryo-Cell International, Inc.
 patents
4. 1 out of 51 
 
Medical College of Georgia
 patents
5. 1 out of 1 
 
Office of General Counsel—psg IV (024)
 patent
6. 1 out of 5,644 
 
The University of Texas System
 patents
where one patent can have more than one assignee

Years Active: 1997-2020

Loading Chart...
Areas of Expertise:
Stem Cell Delivery
Neural Stem Cells
Blood Brain Barrier
Cognitive Deficits
Neuroprotection
Cryopreservation
Sertoli Cells
Neurological Disorders
Spinal Cord Pathology
Combination Therapy
Epilepsy Treatment
Stroke Treatment
14 patents (USPTO):Explore Patents
1. 10765706 - Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers (2020-09-08),
2. 10357517 - Methods of treating epilepsy using neural stem cells that express nanog, SSEA-4, OCT-4, MIR-34B, MIR-34C and MIR-592 (2019-07-23),
3. 10285935 - Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology (2019-05-14),
4. 10130683 - Combination therapy of stem cell mobilizing agents and stem cell transplantation (2018-11-20),
5. 9822359 - Method of treating neurological disorders using long non-coding RNAs (2017-11-21),
6. 9044431 - Methods of treating stroke using stem cell-like menstrual blood cells (2015-06-02),
7. 8618167 - Methods of attenuating cognitive deficits with sulfonyl fluorides (2013-12-31),
8. 7674457 - Methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers (2010-03-09),
9. 6649160 - Sertoli cells as transplantation facilitator for cell transplantation (2003-11-18),
10. 6037175 - Method and media for enhancing cryopreservation of cells (2000-03-14),
11. 6036951 - Sertoli cells as neurorecovery inducing cells for neurodegenerative (2000-03-14),
12. 5942437 - Method and media for enhancing viability maturation, and (1999-08-24),
13. 5830460 - Sertoli cells as transplantation facilitator for cell transplantation (1998-11-03),
14. 5702700 - Sertoli cells as neurorecovery inducing cells for Parkinson's disease (1997-12-30),

Title: Inventor Cesario V Borlongan: Pioneering Advances in Stem Cell Research

Introduction

Cesario V Borlongan is a prominent inventor based in Odessa, Florida, USA, known for his groundbreaking contributions to the field of stem cell research. With an impressive portfolio of 14 patents, he has made significant strides in understanding and treating neurological conditions that affect millions worldwide.

Latest Patents

Among his latest innovations, Cesario V Borlongan has developed a method for stem cell delivery into the brain during chronic disease using blood-brain barrier (BBB) permeabilizers. This innovative approach utilizes substances like mannitol to enhance the entry of stem cells from outside the brain into areas affected by stroke. His research indicates that BBB permeation during the chronic stages of stroke can facilitate this entry, demonstrating notable behavioral and histological improvements when using human umbilical cord stem cells (hUCBC) in combination with mannitol. Additionally, he has proposed methods of treating epilepsy by utilizing neural stem cells expressing specific markers that can be instrumental in diagnosing and treating epilepsy-related disorders.

Career Highlights

Throughout his career, Borlongan has worked extensively at the University of South Florida and collaborated with The United States of America, represented by the Department of Veterans Affairs. His work reflects a deep commitment to advancing medical science and improving therapeutic outcomes for patients suffering from neurological disorders.

Collaborations

Cesario V Borlongan has collaborated with esteemed colleagues including Paul R Sanberg and Don F Cameron. These partnerships have fostered innovative research and development efforts, contributing to the growth and enhancement of the field of stem cell therapy.

Conclusion

Cesario V Borlongan stands out as an influential inventor in the realm of stem cell research, with a focus on neurological diseases. His dedication to exploring and implementing innovative approaches continues to make a meaningful impact on the medical community and the lives of patients facing chronic health challenges. With a robust array of patents and collaborative efforts, he continues to advance the boundaries of scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…